News
Latest News
Contact Us
The MSC: Regeneration Orchestrator
04/08/2022
The Scientist, November 16, 2020 Scientists uncover the promise of mesenchymal stem cells (MSCs), also known as medicinal signaling cells, to modulate the immune system
Unique Aspects of Cord Blood Banking in the UK
03/08/2022
Parent’s Guide to Cord Blood, November 2020 Kate Sneddon Since the inception of umbilical cord blood stem cell cryopreservation, the number of public and privately banked units
10 Amazing Facts About the Placenta
02/08/2022
Parent’s Guide to Cord Blood, October, 2020 Liat Ben-Senior, MBA MSc The placenta is the lifeline between a mom and her baby. It is the
Study reveals how smoking worsens COVID-19 infection in the airways
01/08/2022
Science Daily, November 17, 2020 UCLA researchers using a model of airway tissue created from human stem cells have pinpointed how smoking cigarettes causes more
Phase 3 Osteoarthritis Clinical Trial Commences
31/07/2022
Cynata Therapeutics Limited, November 11, 2020 MELBOURNE, Australia, Nov. 11, 2020 (GLOBE NEWSWIRE) — Cynata Therapeutics Limited (ASX: “CYP”, “Cynata”, or the “Company”), a clinical-stage biotechnology company
IMAC Holdings, Inc. Announces Opening Enrollment in Its Phase 1 Clinical Study of Umbilical Cord – Derived Mesenchymal Stem Cells for the Treatment of Bradykinesia Due to Parkinson’s Disease
30/07/2022
IMAC Holdings, Inc., November 05, 2020 BRENTWOOD, Tenn, Nov. 05, 2020 (GLOBE NEWSWIRE) — IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or “the Company”), a provider of innovative medical advancements and
New gelatin microcarrier for cell production
29/07/2022
Gelatin-based microcarriers offer higher yield and scalability compared to existing commercial microcarriers Science Daily, October 29, 2020 Researchers developed a novel microcarrier for large-scale cell
Stem cell sheets harvested in just two days
28/07/2022
Science Daily, October 08, 2020 Stem cells are cell factories that constantly divide themselves to create new cells. Implanting stem cells in damaged organs can
Affimed Announces Dosing of First Patient in Phase 1 Clinical Trial of Cord Blood-derived Natural Killer Cells in Combination with the Innate Cell Engager AFM13
27/07/2022
Press Release – October 6, 2020 First of its kind clinical study combining a Natural Killer (NK) cell product with an innate cell engager (ICE®)
Current uses of Cord Blood for Immunotherapy
26/07/2022
Parent’s Guide to Cord Blood, October 2020 Frances Verter, PhD There is optimism in the cord blood community that cord blood units can be used
